SR

Shipra Rani

Active Director Director DIN 10330668
DIN 10330668 First appointment Oct 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Oct 2023
Shareholding value Locked Premium profile

About Shipra Rani

Shipra Rani has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Maladiaid Health And Research Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 10330668
Primary Designation Director
First Appointment 07 Oct 2023
Oldest Company Age 3 yrs

Current companies

Company Designation Appointment Founded Status
Director 07 Oct 2023 2022 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Maladiaid Health And Research Private Limited
Premium access

Shareholding and investment profile for Shipra Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shipra Rani

Shipra Rani has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Maladiaid Health And Research Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Shipra Rani is associated with 1 company as Director.

Shipra Rani has expertise in Healthcare.

Shipra Rani has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available